Yakult Honsha Co.,Ltd.
2267
株式のランク
#3393
Yakult Honsha Co.,Ltd. is a diversified Japanese enterprise engaged in the... Yakult Honsha Co.,Ltd. is a diversified Japanese enterprise engaged in the manufacturing and sale of a broad array of products, including food and beverages, cosmetics, and pharmaceuticals. The company's operations are segmented geographically for its Food and Beverages division, covering Japan, the Americas, Asia and Oceania, and Europe, alongside dedicated Pharmaceutical and "Others" segments. Its extensive food and beverage offerings feature popular items such as fermented milk beverages, various juices, and noodle products, which are distributed through both a home delivery service and traditional retail channels. In the pharmaceutical sector, Yakult Honsha provides specific medications like the antineoplastic drug Elplat, along with a suite of generic anti-cancer treatments, including Gemcitabine Yakult, Capecitabine, and Gefitinib Yakult tablets. Furthermore, the company maintains a presence in the cosmetics industry and is notably the owner of the professional baseball team, the Tokyo Yakult Swallows. Founded in 1935, Yakult Honsha Co.,Ltd. is headquartered in Tokyo, Japan.
株価
$17.82
時価総額
$5.13B
変化（1日）
0.07%
変化（1年）
11.64%
国
JP
取引 Yakult Honsha Co.,Ltd. (2267)
カテゴリー
Consumer Defensive
Yakult Honsha Co.,Ltd.（2267）の収益
Oct 2026 時点の収益 TTM: 0
Yakult Honsha Co.,Ltd. の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Yakult Honsha Co.,Ltd. の収益履歴（2026 ～ 2026）
各年末の収益
| 年 | 収益 | 変化 |
|---|---|---|
| 提供された日付のデータは十分ではありません。 | ||
同業他社の収益
| 企業 | 収益 | 収益の差 | 国 |
|---|---|---|---|
| $50.13B | - |
US
|
|
| $98.24B | - |
US
|
|
| $9.22B | - |
US
|
|
| $8.15B | - |
CN
|
|
| $20.09B | - |
US
|
